Completion of Hangzhou Xiaoshan Production Center

As an emerging interdisciplinary discipline, synthetic biology is one of the important fields to promote national innovation and development. As the highland of China's biopharmaceutical industry and the first domestic prefecture-level city-level synthetic biology policy, the newly released "Measures to Support the High-quality Development of Synthetic Biology Industry in Hangzhou" focuses on three aspects: enhancing innovation and R&D capability, promoting industrial cluster development, and improving the eco-service system. 


-The newly released "Several Measures for Supporting the High-Quality Development of Synthetic Biology Industry in Hangzhou" focuses on three aspects, including enhancing the innovation and R&D capability, promoting the development of industry agglomeration, and improving the ecological service system.

The production base is a wholly-owned subsidiary of JAJALE BIOTECH, constructing an internationally leading synthetic biology pilot and mass production base. 

The founder, Mr. Lu Yuele, signed the contract with Xiaoshan Economic Development Zone. JIACHI BIO is a synthetic biology pilot and mass production platform built by jajale, which will set up a precision fermentation system, an integrated membrane system, a continuous ion exchange system, a three-in-one drying system, a multi-dimensional data acquisition and analysis system, and complete the construction of a GMP production workshop at the same time. On this basis, Gamma Bio, together with Gala, will better serve domestic and overseas customers by providing high-quality and high-activity synthetic biology products, as well as whole-link, systematic solutions simultaneously.